UC researcher uses historical control group for new osteoporotic fracture analysis.(Actonel clinical trials conducted without a placebo control group)

Publication: Women's Health Weekly

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2002 NewsRX

2002 AUG 15 - (NewsRx.com & NewsRx.net) -- In a new analysis of a study funded by Procter & Gamble Pharmaceuticals, Nelson Watts, MD, professor of medicine at the University of Cincinnati (UC) and director of the UC Bone Health and Osteoporosis Center, has applied an innovative new method for analyzing fracture efficacy...

Read the full article for free courtesy of your local library.